Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms.
Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, Li D, Tafuto S, Raj N, Campana D, Hijioka S, Raderer M, Guimbaud R, Gajate P, Pusceddu S, Reising A, Degtyarev E, Shilkrut M, Eddy S, Singh S.
Yao JC, et al. Among authors: singh s.
Endocr Relat Cancer. 2021 Jan 1:ERC-20-0382.R1. doi: 10.1530/ERC-20-0382. Online ahead of print.
Endocr Relat Cancer. 2021.
PMID: 33480358